GL1X · GenesisL1 explorer

MolNFT v1 · #83982 · protein

Kdr in complex with ligand lenvatinib

3WZD · Vascular endothelial growth factor receptor 2: “Kdr in complex with ligand lenvatinib”. X-ray diffraction, 2 ligands (LEV, SO4), 2 pockets (best druggability 0.64). MolNFT v1 #83982 on GenesisL1: 3D structure, binding sites and…

PDB
3WZD
Type
protein
Length
278 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
LEV, SO4
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein27844% helix, 15% strandP35968

Ligands and binding sites

  • LEV · 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • DTT · 2,3-dihydroxy-1,4-dithiobutane · additive · 4 copies · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12380.640.8226LEV, GOL
2750.420.8016empty

Modifications

Observed in the structure: 4 covalent (additive adduct).

Compared structures

  • 3WZD · KDR in complex with ligand lenvatinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.